What is KADCYLA used for?
KADCYLA is a HER2-targeted antibody and microtubule inhibitor conjugate indicated, as a single agent, for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:
1. Received prior therapy for metastatic disease, or 2. Developed disease recurrence during or within six months of completing adjuvant therapy.
Please contact +91 9811747774 for KADCYLA (ado-trastuzumab emtansine) for injection cost in India
Where can I buy KADCYLA?
Indian Pharma Network helps patients, doctors and hospitals as a facilitator to import prescription medicine. Brand: KADCYLA. Generic: ado-trastuzumab emtansine on prescription and Import License in Patient's Name only.
Brand: KADCYLA is manufactured by Genentech, Inc.
KADCYLA can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable